Table 1: Baseline characteristics for 42 patients with advanced gastro-esophageal adenocarcinoma treated with DOX.

Number of patients

42

Age, years

Median

range

 

64

44-76

Sex

 Male

 Female

 

36 (86%)

 6 (14%)

WHO performance status

 0

 1

 

24 (57%)

18 (43%)

Primary tumour site

Esophagus

GEJ

Stomach

 

12 (28%)

23 (55%)

7 (17%)

Status of primary tumour

 R0 resection

 R2 resection

 No surgery

No patient had prior CT or RT

 5 (12%)

1 (2%)

36 (86%)

Stage

 Locally advanced

 Metastatic

 

3 (7%)

39 (93%)

No. of organs involved

1

2

3

 ≥ 4

 

2 (5%)

14 (36%)

14 (36%)

9 (23%)

Increased

 Alkaline phosphatase (> 300 U/l)

ALAT (> 40 U/l)

Platelets (> 400 × 109 /l)

ANC (> 7.5 × 109 /l)

 

4 (10%)

6 (14%)

14 (33%)

22 (52%)